Natural Alternatives International, Inc. logo

Natural Alternatives International, Inc.

NAII

NASDAQConsumer DefensivePackaged Foods

Previous close

$2.15

+$0.08 · +3.86%

Aug 21, 4:00 PM ET

NAII company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

47

Fair Value

Momentum

27

Weakening

Sentiment

55

Mixed

Risk resilience

43

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.

Industry
Packaged Foods
Sector
Consumer Defensive
Headquarters
US
CEO
Mark A. LeDoux
Listed since
Oct 28, 1993
Employees
293

Market position

Day range

Current $2.15

52-week range

Current $2.15

Open
$2.255
Previous close
$2.07
Volume
44.64K
1.3× average
Average volume
34.25K
Average daily volume
Market cap
13.49M USD
Beta
0.37
Market reference 1
50-day average
$2.3092
-6.89% below average
200-day average
$2.8916
-25.65% below average

Earnings

Latest EPS result
-0.72

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates-0.04-0.29-0.53-0.77Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Q3 2024, reported Sep 27, 2024: actual -0.32, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Nov 13, 2024: actual -0.33, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual -0.37, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual -0.37, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 23, 2025: actual -0.17, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 12, 2025: actual -0.05, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual -0.42, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 18, 2026: actual -0.72, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates36.71M33.59M30.47M27.35MQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Q3 2024, reported Sep 27, 2024: actual 29.49M USD, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Nov 13, 2024: actual 33.15M USD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual 34.08M USD, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 28.77M USD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 23, 2025: actual 33.87M USD, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 12, 2025: actual 33.87M USD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 34.5M USD, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 18, 2026: actual 35.3M USD, estimate —, surprise —, Comparison unavailable.

NAII news

NAII peers

ETFs holding NAII

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research NAII

research.disclaimer